Lessons from the POCT FrontHow Can Labs Improve Implementation, Tackle Compliance Challenges?By Genna Rollins
Despite its popularity, point-of-care testing continues to pose challenges for laboratorians and clinicians. Veterans from the field offer tips for successfully implementing and sustaining POCT programs.
NCI Launches National BiobankWhy High-Quality Specimens Have Researchers ExcitedBy Bill Malone
As biomedical research advances, the need for high-quality human specimens has become more acute, especially in laboratory medicine where specimens are needed to discover new biomarkers, develop assays, and validate tests for clinical use. Now a national biobank project launched by the National Cancer Institute aims to help solve this problem with the high-quality standards required to develop new tests.
Lead TestingMeeting the Analytical Demands of Identifying Exposed ChildrenBy Kathleen L. Caldwell, PhD, and Robert Jones, PhD
Despite the seriousness of the disorder, relatively little is known about the causes of preeclampsia and how to monitor this disease. The lab could become increasing important in determining the risk for developing preeclampsia, as new biomarkers become available for earlier detection.
Bad News: Abnormal Lipid Levels in Teenagers
Key Flu Indicators Level Off FDA’s Emergency Use Authorizations for Detecting the 2009 H1N1 Virus
The 2009 H1N1 public health emergency has led the FDA to permit limited use of 13 assays for the virus.
Download the entire issue
Emerging Biomarkers for Diagnosis of Liver Disease